Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy Doximity stock (Doximity)

Buy Doximity stock in 5 easy steps, view past price performance and learn what’s ahead for the company.

Doximity is a health information services business based in the US. Doximity shares (DOCS) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $54.20 – an increase of 1.23% over the previous week. Doximity employs 827 staff and has a trailing 12-month revenue of around $516.8 million.

Our top picks for where to buy Doximity stock

Our pick for investing by theme

Go to site
  • Trade $0 commission stocks & ETFs with as little as $1
  • Earn up to $300 with qualifying deposits
  • Discover new opportunities with Opto's AI-driven thematic investing system
  • Theme and ETF screener

Top pick for best mobile experience

Go to site
  • Trade $0 commission stocks, ETFs, and options with as little as $1
  • After-hours trading available
  • Earn 4.5% interest on uninvested cash with Gold
  • 24/7 customer support

Our pick for transfer bonus

Go to site
  • Trade stocks, options, ETFs, mutual funds, alternative asset funds
  • $0 commission on stocks, ETFs and options with no options contract fees
  • Complimentary access to a financial planner

How to buy Doximity stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – DOCS. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy Doximity stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 6 of 6
Name Product USFST Ratings Available asset types Stock trade fee Minimum deposit Cash sweep APY Signup bonus
OPTO
Finder Score: 3.8 / 5: ★★★★★
OPTO
★★★★★
Stocks, ETFs
$0
$0
N/A
Earn up to $300
AI-driven thematic investing, with proprietary research, fractional shares and commission-free stocks and ETFs.
Robinhood
Finder Score: 4.6 / 5: ★★★★★
Robinhood
★★★★★
Stocks, Options, ETFs, Cryptocurrency
$0
$0
4.5%
Get a free stock
Trade stocks, options, ETFs and crypto without commissions and on a user-friendly platform. Plus, a 1% IRA match and no options contract fees.
SoFi Invest®
Finder Score: 4.3 / 5: ★★★★★
SoFi Invest®
★★★★★
Stocks, Options, Mutual funds, ETFs, Alternatives
$0
$0
0.02%
Get up to $1,000 in stock
Zero-commission stocks, ETFs and options, with no options per-contract fees. Plus, a complimentary access to financial planners.
Uphold
Finder Score: 3.6 / 5: ★★★★★
Crypto alternative
Uphold
★★★★★
Cryptocurrency
N/A
$0
4.65%
Get $10
Tastytrade
Finder Score: 4.4 / 5: ★★★★★
Tastytrade
★★★★★
Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills
$0
$0
N/A
Get $50-$5,000
Competitive, capped options commissions, with a reliable trading platform designed for serious traders.
Public.com
Finder Score: 4.4 / 5: ★★★★★
Public.com
★★★★★
Stocks, Bonds, Options, ETFs, Cryptocurrency, Alternatives, Treasury Bills, High-yield cash account
$0
$0
4.35%
Get up to $10,000 and transfer fees covered
Build a diversified portfolio of stocks, bonds, options, ETFs, crypto and alternative assets, with a high-yield cash account and options contract rebates.
loading

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Doximity stock price (NYSE: DOCS)

Use our graph to track the performance of DOCS stocks over time.

Doximity shares at a glance

Information last updated 2024-11-28.
Latest market close$54.20
52-week range$22.96 - $61.75
50-day moving average $45.10
200-day moving average $32.90
Wall St. target price$56.75
PE ratio 61.3678
Dividend yield N/A
Earnings per share (TTM) $0.87

Is it a good time to buy Doximity stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Doximity price performance over time

Historical closes compared with the close of $53 from 2024-11-29

1 week (2024-11-26) -1.01%
1 month (2024-11-04) 26.73%
3 months (2024-09-03) 47.63%
6 months (2024-06-03) 91.75%
1 year (2023-12-01) 117.66%
2 years (2022-12-02) 49.42%
3 years (2021-12-03) 59.86
5 years (2019-11-30) N/A

Is Doximity stock undervalued or overvalued?

Valuing Doximity stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Doximity's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Doximity's P/E ratio

Doximity's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 61x. In other words, Doximity shares trade at around 61x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

However, Doximity's P/E ratio is best considered in relation to those of others within the health information services industry or those of similar companies.

Doximity's PEG ratio

Doximity's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.4191. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Doximity's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

However, it's sensible to consider Doximity's PEG ratio in relation to those of similar companies.

Doximity's EBITDA

Doximity's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $207.9 million.

The EBITDA is a measure of a Doximity's overall financial performance and is widely used to measure a its profitability.

To put Doximity's EBITDA into context you can compare it against that of similar companies.

Doximity financials

Revenue TTM $516.8 million
Operating margin TTM 40.68%
Gross profit TTM $365.6 million
Return on assets TTM 11.83%
Return on equity TTM 19%
Profit margin 33.69%
Book value $5.15
Market Capitalization $10 billion

TTM: trailing 12 months

Doximity share dividends

We're not expecting Doximity to pay a dividend over the next 12 months.

You may also wish to consider:

Doximity share price volatility

Over the last 12 months, Doximity's shares have ranged in value from as little as $22.96 up to $61.75. A popular way to gauge a stock's volatility is its "beta".

DOCS.US volatility(beta: 1.3)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Doximity's is 1.296. This would suggest that Doximity's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

To put Doximity's beta into context you can compare it against those of similar companies.

Doximity overview

Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with digital tools built for medicine, that enables its members to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. It primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010.

Frequently asked questions

null
What percentage of Doximity is owned by insiders or institutions?
Currently 2.717% of Doximity shares are held by insiders and 92.143% by institutions.
How many people work for Doximity?
Latest data suggests 827 work at Doximity.
When does the fiscal year end for Doximity?
Doximity's fiscal year ends in March.
Where is Doximity based?
Doximity's address is: 500 3rd Street, San Francisco, CA, United States, 94107
What is Doximity's ISIN number?
Doximity's international securities identification number is: US26622P1075

More guides on Finder

Ask a question

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site